Short Communication - Journal of Clinical Immunology Research (2022) Volume 5, Issue 1

COVID-19 in immunocompromised hosts: Clinical experiences and implications.

Patients and overburdened healthcare systems around the world have been affected by the COVID-19 pandemic, which was caused by the severe acute respiratory syndrome coronavirus 2. The clinical characteristics and prognosis of COVID-19 in immunocompromised patients, who are thought to be at higher risk of severe disease but may also have fewer harmful inflammatory responses, are not well understood.

Author(s): Yun Zhang

Abstract Full Text PDF